AMLX
Price
$14.59
Change
+$0.68 (+4.89%)
Updated
Jun 12 closing price
Capitalization
1.62B
53 days until earnings call
Intraday BUY SELL Signals
CRDL
Price
$1.03
Change
-$0.04 (-3.74%)
Updated
Jun 12 closing price
Capitalization
120.44M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs CRDL

Header iconAMLX vs CRDL Comparison
Open Charts AMLX vs CRDLBanner chart's image
AMLX vs CRDL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AMLX vs. CRDL commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and CRDL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2026
Stock price -- (AMLX: $14.59 vs. CRDL: $1.03)
Brand notoriety: AMLX and CRDL are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMLX: 145% vs. CRDL: 56%
Market capitalization -- AMLX: $1.62B vs. CRDL: $120.44M
AMLX [@Pharmaceuticals: Generic] is valued at $1.62B. CRDL’s [@Pharmaceuticals: Generic] market capitalization is $120.44M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileCRDL’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • CRDL’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than CRDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 5 TA indicator(s) are bullish while CRDL’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 5 bullish, 5 bearish.
  • CRDL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than CRDL.

Price Growth

AMLX (@Pharmaceuticals: Generic) experienced а +9.53% price change this week, while CRDL (@Pharmaceuticals: Generic) price change was -7.21% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.56%. For the same industry, the average monthly price growth was +23.25%, and the average quarterly price growth was +9.77%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 06, 2026.

CRDL is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.56% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.62B) has a higher market cap than CRDL($120M). AMLX YTD gains are higher at: 20.778 vs. CRDL (7.989). CRDL has higher annual earnings (EBITDA): -35.49M vs. AMLX (-158.8M). AMLX has more cash in the bank: 280M vs. CRDL (27.7M). CRDL has less debt than AMLX: CRDL (116K) vs AMLX (5.63M). AMLX (0) and CRDL (0) have equivalent revenues.
AMLXCRDLAMLX / CRDL
Capitalization1.62B120M1,352%
EBITDA-158.8M-35.49M447%
Gain YTD20.7787.989260%
P/E Ratio2.69N/A-
Revenue00-
Total Cash280M27.7M1,011%
Total Debt5.63M116K4,854%
FUNDAMENTALS RATINGS
CRDL: Fundamental Ratings
CRDL
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXCRDL
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 24 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signal:
Gain/Loss:
CRDL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BEX48.813.82
+8.49%
Tradr 2X Long BE Daily ETF
FLOW38.800.19
+0.50%
Global X U.S. Cash Flow Kings 100 ETF
YLDW25.730.09
+0.36%
Westwood Enhanced Income Opportunity ETF
BKGI45.88N/A
N/A
BNY Mellon Global Infras Inc ETF
FICS41.30-0.03
-0.06%
First Trust Intl Developed Cap Strth ETF

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+4.89%
XOMAO - AMLX
68%
Closely correlated
+0.16%
XOMAP - AMLX
51%
Loosely correlated
-0.18%
OCUL - AMLX
46%
Loosely correlated
+2.76%
LRMR - AMLX
45%
Loosely correlated
-3.61%
JAZZ - AMLX
43%
Loosely correlated
-2.38%
More

CRDL and

Correlation & Price change

A.I.dvisor tells us that CRDL and ACB have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
-3.74%
ACB - CRDL
31%
Poorly correlated
-1.30%
LNTH - CRDL
29%
Poorly correlated
+0.19%
TLRY - CRDL
25%
Poorly correlated
-2.73%
EOLS - CRDL
25%
Poorly correlated
+3.38%
AMLX - CRDL
24%
Poorly correlated
+4.89%
More